Physician

Adam D Quick, MD

According to 2025 Medicare claims, Adam Quick, MD (NPI: 1437283918) practices neurology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU NEUROSCIENCE CENTER LLC (NPI: 1962431817; TIN: 232743545) and primary practice location at 43221-3502. Quick is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Quick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 165 traditional Medicare patients, billed 638 HCPCS/CPT codes, and received $28,901 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 566 prescription claims across 91 beneficiaries totaling $821,449 in drug costs, led by Radicava Ors (Edaravone). DME data shows 13 claims. Open Payments data shows 10 records totaling $39,335. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $39,376 to $28,901. In contrast, Part D prescription costs have risen steadily, from $212,236 to $821,449. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $11,812 and ending at $29,057.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	235	641	$39,376
2016	309	1,016	$60,441
2017	300	728	$44,485
2018	238	617	$38,394
2019	262	1,363	$43,850
2020	243	548	$35,367
2021	204	1,092	$35,681
2022	192	777	$27,155
2023	181	412	$25,638
2024	165	638	$28,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	589	$212,236
2016	98	750	$152,571
2017	101	828	$147,677
2018	109	911	$511,854
2019	120	860	$378,152
2020	112	885	$501,837
2021	109	716	$538,586
2022	96	577	$613,250
2023	95	653	$2,074,943
2024	91	566	$821,449

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	32	$2,129
2017	N/R	14	$791
2018	N/R	11	$889
2019	N/R	99	$23,366
2020	N/R	29	$1,689
2021	N/R	53	$4,939
2022	N/R	72	$9,141
2023	N/R	60	$5,297
2024	N/R	13	$1,697

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	24	24	$120
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	61	$97
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	51	62	$33
95885	Needle measurement of electrical activity in arm or leg muscles, limited study	36	43	$14
94010	Test to measure expiratory airflow and volume	21	29	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Radicava Ors	Edaravone	30	840	$431,116
Relyvrio	Sod Phenylbutyrat/Taurursodiol	28	784	$363,507
Riluzole	Riluzole	88	3,272	$9,037
Pregabalin	Pregabalin	71	3,030	$2,249
Mycophenolate Mofetil	Mycophenolate Mofetil	17	810	$2,067

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	N/R	13	$1,697

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$39,335	ARGENX US, INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam D. Quick, MD?

Tedicare shows public-source Medicare data for Adam D. Quick, MD (NPI 1437283918), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam D. Quick, MD have ACO affiliation data?

Adam D. Quick, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Adam D. Quick, MD?

Adam D. Quick, MD is linked to OSU NEUROSCIENCE CENTER LLC (billing NPI 1962431817) in the available physician profile data.

Does Adam D. Quick, MD have Open Payments data?

Adam D. Quick, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.